Biomarkers in whichever modality are tremendously important in diagnosing of disease,
tracking disease progression and clinical trials. This applies in particular for disorders with a …

Aging and mild cognitive impairment (MCI) are accompanied by decline of cognitive
functions. Meanwhile, the most common form of dementia is Alzheimer's disease (AD) …

Background Alzheimer's disease (AD) is a neurodegenerative disorder with significant
heterogeneity. Different AD phenotypes may be associated with specific brain network …

Hypersynchronization has been proposed as a synaptic dysfunction biomarker in the
Alzheimer's disease continuum, reflecting the alteration of the excitation/inhibition balance …

Background: Recent studies have discovered that functional connections are impaired
among patients with Alzheimer's disease (AD), even at the preclinical stage. The cerebellum …

Spontaneous slow oscillation-associated slow wave activity represents an internally
generated state which is characterized by alternations of network quiescence and …

Episodic memory decline is the prominent neuropsychological feature of typical Alzheimer's
Disease (AD), for which current treatments have a limited clinical response. Recently …

Background Mild cognitive impairment (MCI) depicts a transitory phase between healthy
elderly and the onset of Alzheimer's disease (AD) with worsening cognitive impairment …

Alzheimer's disease (AD) is associated with disruptions in brain activity and networks.
However, there is substantial inconsistency among studies that have investigated functional …

Introduction: Alzheimer's disease (AD) and behavioral variant frontotemporal dementia
(bvFTD) are the most common types of early-onset dementia. Early differentiation between …